File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1128/JCM.43.4.1594-1599.2005
- Scopus: eid_2-s2.0-16844380547
- PMID: 15814971
- WOS: WOS:000228404100014
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Determinants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearance
Title | Determinants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearance |
---|---|
Authors | |
Issue Date | 2005 |
Publisher | American Society for Microbiology. |
Citation | Journal of Clinical Microbiology, 2005, v. 43 n. 4, p. 1594-1599 How to Cite? |
Abstract | This study was performed to determine the factors for predicting the occurrence of acute exacerbation of hepatitis B virus infection in HBeAg-negative patients. Two hundred and sixteen patients with known times of HBeAg seroclearance were recruited. Liver biochemistry and virologic markers were monitored. Precore and core promoter mutations were determined by a line probe assay. The median age at HBeAg seroclearance was 34.5 years. The median follow-up duration was 26.4 months. Fifty-six (27.9%) patients had acute exacerbations. By Cox regression analysis, male gender, older age, and core promoter mutations at the time of HBeAg seroclearance were independently associated with the occurrence of acute exacerbation after HBeAg seroclearance (P = 0.025, 0.018, and 0.001, respectively). Fourteen (7.0%) patients had HBeAg seroreversion within a median follow-up period of 11.6 months after HBeAg seroclearance. By Cox regression analysis, older age at HBeAg seroclearance was independently associated with the chance of HBeAg seroreversion (P = 0.01). We concluded that male patients with core promoter mutations and delayed HBeAg seroclearance had a higher cumulative chance of acute exacerbation in the HBeAg-negative phase. Patients with delayed HBeAg seroclearance had a higher frequency of HBeAg seroreversion. Copyright © 2005, American Society for Microbiology. All Rights Reserved. |
Persistent Identifier | http://hdl.handle.net/10722/49134 |
ISSN | 2023 Impact Factor: 6.1 2023 SCImago Journal Rankings: 1.653 |
PubMed Central ID | |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yuan, HJ | en_HK |
dc.contributor.author | Yuen, MF | en_HK |
dc.contributor.author | Wong, DKH | en_HK |
dc.contributor.author | Sum, SM | en_HK |
dc.contributor.author | Doutreloigne, J | en_HK |
dc.contributor.author | Sablon, E | en_HK |
dc.contributor.author | Lai, CL | en_HK |
dc.date.accessioned | 2008-06-12T06:35:09Z | - |
dc.date.available | 2008-06-12T06:35:09Z | - |
dc.date.issued | 2005 | en_HK |
dc.identifier.citation | Journal of Clinical Microbiology, 2005, v. 43 n. 4, p. 1594-1599 | en_HK |
dc.identifier.issn | 0095-1137 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/49134 | - |
dc.description.abstract | This study was performed to determine the factors for predicting the occurrence of acute exacerbation of hepatitis B virus infection in HBeAg-negative patients. Two hundred and sixteen patients with known times of HBeAg seroclearance were recruited. Liver biochemistry and virologic markers were monitored. Precore and core promoter mutations were determined by a line probe assay. The median age at HBeAg seroclearance was 34.5 years. The median follow-up duration was 26.4 months. Fifty-six (27.9%) patients had acute exacerbations. By Cox regression analysis, male gender, older age, and core promoter mutations at the time of HBeAg seroclearance were independently associated with the occurrence of acute exacerbation after HBeAg seroclearance (P = 0.025, 0.018, and 0.001, respectively). Fourteen (7.0%) patients had HBeAg seroreversion within a median follow-up period of 11.6 months after HBeAg seroclearance. By Cox regression analysis, older age at HBeAg seroclearance was independently associated with the chance of HBeAg seroreversion (P = 0.01). We concluded that male patients with core promoter mutations and delayed HBeAg seroclearance had a higher cumulative chance of acute exacerbation in the HBeAg-negative phase. Patients with delayed HBeAg seroclearance had a higher frequency of HBeAg seroreversion. Copyright © 2005, American Society for Microbiology. All Rights Reserved. | en_HK |
dc.format.extent | 394 bytes | - |
dc.format.mimetype | text/html | - |
dc.language | eng | en_HK |
dc.publisher | American Society for Microbiology. | en_HK |
dc.relation.ispartof | Journal of Clinical Microbiology | en_HK |
dc.subject.mesh | Hepatitis B e Antigens - blood | en_HK |
dc.subject.mesh | Hepatitis B virus - genetics - isolation & purification - pathogenicity | en_HK |
dc.subject.mesh | Hepatitis B, Chronic - physiopathology - virology | en_HK |
dc.subject.mesh | Liver Function Tests | en_HK |
dc.subject.mesh | Predictive Value of Tests | en_HK |
dc.title | Determinants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearance | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Yuen, MF:mfyuen@hkucc.hku.hk | en_HK |
dc.identifier.email | Wong, DKH:danywong@hku.hk | en_HK |
dc.identifier.email | Lai, CL:hrmelcl@hku.hk | en_HK |
dc.identifier.authority | Yuen, MF=rp00479 | en_HK |
dc.identifier.authority | Wong, DKH=rp00492 | en_HK |
dc.identifier.authority | Lai, CL=rp00314 | en_HK |
dc.description.nature | link_to_OA_fulltext | en_HK |
dc.identifier.doi | 10.1128/JCM.43.4.1594-1599.2005 | en_HK |
dc.identifier.pmid | 15814971 | - |
dc.identifier.pmcid | PMC1081372 | en_HK |
dc.identifier.scopus | eid_2-s2.0-16844380547 | en_HK |
dc.identifier.hkuros | 97680 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-16844380547&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 43 | en_HK |
dc.identifier.issue | 4 | en_HK |
dc.identifier.spage | 1594 | en_HK |
dc.identifier.epage | 1599 | en_HK |
dc.identifier.isi | WOS:000228404100014 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Yuan, HJ=7402446707 | en_HK |
dc.identifier.scopusauthorid | Yuen, MF=7102031955 | en_HK |
dc.identifier.scopusauthorid | Wong, DKH=7401535819 | en_HK |
dc.identifier.scopusauthorid | Sum, SM=6603889132 | en_HK |
dc.identifier.scopusauthorid | Doutreloigne, J=6603727456 | en_HK |
dc.identifier.scopusauthorid | Sablon, E=6603694538 | en_HK |
dc.identifier.scopusauthorid | Lai, CL=7403086396 | en_HK |
dc.identifier.issnl | 0095-1137 | - |